Psyche Portfolio Target Investment Criteria Experienced and seasoned C-Suite & Management Team Strategic and well funded Co-Investors Scalable business model Asset light and/or Low capital needs Data aggregation and analytics Proprietary IP, Technology, product or service Synergy with Phyto portfolio ecosystem 3-6 month due diligence monitoring Visible Exit strategy and Path to monitization Our Investment Portfolio An integrated life science company. Researching, developing, and manufacturing psychotropic compounds. Pioneering the intersection between psychedelic medicine and science. Find ketamine clinics and psychedelic therapies around the globe. A meditation and brain sensing headband that allows you to train your mind.